Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

US Patent 9932338 · Granted Apr 3, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Urolithin derivatives and methods of use thereof2025
Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists2025
Amido cyclohexane acid derivatives as LPA receptor inhibitors2025
Urolithin derivatives and methods of use thereof2025
Urolithin derivatives and methods of use thereof2025
HPK1 antagonists and uses thereof2025
HPK1 antagonists and uses thereof2025
Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists2024
HPK1 antagonists and uses thereof2024
Urolithin derivatives and methods of use thereof2023
Meta tyrosine derivatives as rho-kinase inhibitors2023
Oxadiazole derivatives as Rho-Kinase Inhibitors2023